Altris AI

This year, is featured in 2 research abstracts at the Association for Research in Vision and Ophthalmology (ARVO).

✅ Abstract/Presentation Title: Pilot study on the use of AI to identify and pre-screen patients for an interventional Geographic Atrophy clinical trial

Presentation Type: Poster Session
Session Number: 150
Session Date/Times: May 3, 2026, from 3:15 PM to 5:00 PM

✅ Abstract/Presentation Title: Human Retinal GCL/IPL Thickness as a Structural Indicator of Systemic Inflammation: A Proof-of-Concept OCT–Cytokine Analysis Within the IICM™Platform

Presentation Type: Poster Session
Session Number: 513
Session Date/Times: May 7, 2026, from 8:00 AM to 9:45 AM

Attend to learn how AI Decision Support for OCT Analysis accelerates patient enrollment, reduces screen failure rate, & elevates ophthalmic research.

Big news! Altris AI has obtained the Kingdom of Saudi Arabia Medical Device Marketing Authorization (M**A) from SFDA - هيئة الغذاء والدواء: Saudi Food and Drug Authority. Altris AI is now approved as an AI-powered Clinical Decision Support System in the Kingdom.

This matters. We respect local laws and regulatory frameworks in every country we enter. Patient safety and the trust of Eye Care Professionals is not a checkbox: it is the basis for everything we build.

M**A from SFDA - هيئة الغذاء والدواء is not just a formality. It reflects strict regulatory standards designed to protect patients and ensure safe clinical use. To receive this authorization, our AI-powered Clinical Decision Support System demonstrated:

✅ proven safety and clinical reliability
✅ clear intended medical use
✅ validated performance and accuracy
✅ strong risk management and data security compliance
✅ a certified quality management system (QMS)
✅ real clinical value for patient care

Altris AI was designed to support clinicians with OCT analysis, provide a second opinion in complex cases, and highlight early changes. Adding an extra layer of confidence to OCT analysis. Now, for the Eye Care Specialists from the Kingdom of Saudi Arabia as well!

«AI in Healthcare» is far from being monolithic. There are different tools for different purposes.

Tools like ChatGPT Health, MedLlama, and MedGemma represent a valuable class of AI: broad, flexible, and increasingly capable of supporting general clinical knowledge. Built to give generalized plausible answers. To patients mostly.

is solving a different problem entirely.

Built exclusively for OCT analysis, it detects 30+ retinal pathologies and 40+ biomarkers across scans from multiple device manufacturers. It uses an exclusive, extensive dataset of carefully labelled OCT scans. It works with DICOMs and raw files from 9 OCT. Altris AI has undergone serious regulatory review to receive FDA clearance, CE certificate, Health Canada and be HIPAA and GDPR-compliant.

It’s a precision clinical instrument created for eye care specialists by eye care specialists.